Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Smoking Cessation Pregnancy Data Required For Alternative Warning Use

This article was originally published in The Tan Sheet

Executive Summary

OTC nicotine-replacement therapy manufacturers who wish to use a pregnancy/breastfeeding warning different from new, FDA-revised labeling "will have to provide data to support alternative wording," the agency says.
Advertisement

Related Content

Make Smoking Cessation OTCs As Available As Cigarettes – Petition
Make Smoking Cessation OTCs As Available As Cigarettes – Petition
Make Smoking Cessation OTCs As Available As Cigarettes – Petition
Nicotine Replacement Therapy Prop 65 Warning Unfounded, FDA Tells Court
Nicotine Replacement Therapy Prop 65 Warning Unfounded, FDA Tells Court
Habitrol labeling changes
Prop 65 Smoking Cessation Warnings Not In Conflict With FDA Rules – Court
Nicotine-Replacement Therapy Use By Young Smokers Urged By Researchers
Smoking Rate 25% Annual Reduction Attainable - Surgeon General
Smoking Rate 25% Annual Reduction Attainable - Surgeon General

Topics

Advertisement
UsernamePublicRestriction

Register

PS092965

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel